Trials / Recruiting
RecruitingNCT06646952
CD147 Targeting Nanobody Probe for PET Imaging in Solid Tumors
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Hua Zhu · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to construct a noninvasive approach using 68Ga-NOTA-MAL-NB147 PET/CT to detect the CD147 expression of tumor lesions in patients with Solid tumors and to identify patients benefiting from CD147 targeting treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-FDG | All study participants will undergo one 18F-FDG PET/ CT scan. |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2024-10-17
- Last updated
- 2024-12-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06646952. Inclusion in this directory is not an endorsement.